Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis

Standard

Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis. / Schultheiß, Christoph; Germany, Department of Internal Medicine IV Oncology/Hematology Martin-Luther-University Halle-Wittenberg; Willscher, Edith; Oberle, Anna; Fanchi, Lorenzo; Bonzanni, Nicola; Wildner, Nils H; Schulze-Zur-Wiesch, Julian; Weiler-Normann, Christina; Lohse, Ansgar W; Binder, Mascha.

in: HEPATOLOGY, Jahrgang 73, Nr. 4, 04.2021, S. 1436-1448.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Schultheiß, C, Germany, DOIMIVOHM-L-UH-W, Willscher, E, Oberle, A, Fanchi, L, Bonzanni, N, Wildner, NH, Schulze-Zur-Wiesch, J, Weiler-Normann, C, Lohse, AW & Binder, M 2021, 'Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis', HEPATOLOGY, Jg. 73, Nr. 4, S. 1436-1448. https://doi.org/10.1002/hep.31473

APA

Schultheiß, C., Germany, D. O. I. M. IV. OH. M-L-U. H-W., Willscher, E., Oberle, A., Fanchi, L., Bonzanni, N., Wildner, N. H., Schulze-Zur-Wiesch, J., Weiler-Normann, C., Lohse, A. W., & Binder, M. (2021). Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis. HEPATOLOGY, 73(4), 1436-1448. https://doi.org/10.1002/hep.31473

Vancouver

Schultheiß C, Germany DOIMIVOHM-L-UH-W, Willscher E, Oberle A, Fanchi L, Bonzanni N et al. Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis. HEPATOLOGY. 2021 Apr;73(4):1436-1448. https://doi.org/10.1002/hep.31473

Bibtex

@article{44db5c9f3cbf49b5801b572bc535104f,
title = "Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis",
abstract = "BACKGROUND AND AIMS: Autoimmune hepatitis (AIH) is a chronic liver disease that regularly relapses when immunosuppression is tapered. It is thought to be driven by T-cells, whereas the etiologic impact of an apparently deregulated B lineage system, as evidenced by hypergammaglobulinemia and autoantibodies, remains elusive. We set out to investigate T and B cell repertoires supporting chronic inflammation in AIH.APPROACH AND RESULTS: T and B cell receptor (TCR/BCR) and human leukocyte antigen (HLA) next-generation immunosequencing were used to record immune signatures from a cohort of 60 patients with AIH and disease controls. Blood and liver B lineage immune metrics were not indicative of a dominant directional antigen selection apart from a slight skewing of IGHV-J genes. More importantly, we found strong AIH-specific TRBV-J skewing not attributable to the HLA-DRB1 specificities of the cohort. This TCR repertoire bias was generated as a result of peripheral T cell (de)selection and persisted in disease remission. Using a clustering algorithm according to antigenic specificity, we identified liver TCR clusters that were shared between patients with AIH but were absent or deselected in patients with other liver pathologies.CONCLUSIONS: Patients with AIH show profound and persisting T-cell architectural changes that may explain high relapse rates after tapering immunosuppression. Liver T-cell clusters shared between patients may mediate liver damage and warrant further study.",
author = "Christoph Schulthei{\ss} and Germany, {Department of Internal Medicine IV Oncology/Hematology Martin-Luther-University Halle-Wittenberg} and Edith Willscher and Anna Oberle and Lorenzo Fanchi and Nicola Bonzanni and Wildner, {Nils H} and Julian Schulze-Zur-Wiesch and Christina Weiler-Normann and Lohse, {Ansgar W} and Mascha Binder",
note = "{\textcopyright} 2020 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.",
year = "2021",
month = apr,
doi = "10.1002/hep.31473",
language = "English",
volume = "73",
pages = "1436--1448",
journal = "HEPATOLOGY",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis

AU - Schultheiß, Christoph

AU - Germany, Department of Internal Medicine IV Oncology/Hematology Martin-Luther-University Halle-Wittenberg

AU - Willscher, Edith

AU - Oberle, Anna

AU - Fanchi, Lorenzo

AU - Bonzanni, Nicola

AU - Wildner, Nils H

AU - Schulze-Zur-Wiesch, Julian

AU - Weiler-Normann, Christina

AU - Lohse, Ansgar W

AU - Binder, Mascha

N1 - © 2020 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.

PY - 2021/4

Y1 - 2021/4

N2 - BACKGROUND AND AIMS: Autoimmune hepatitis (AIH) is a chronic liver disease that regularly relapses when immunosuppression is tapered. It is thought to be driven by T-cells, whereas the etiologic impact of an apparently deregulated B lineage system, as evidenced by hypergammaglobulinemia and autoantibodies, remains elusive. We set out to investigate T and B cell repertoires supporting chronic inflammation in AIH.APPROACH AND RESULTS: T and B cell receptor (TCR/BCR) and human leukocyte antigen (HLA) next-generation immunosequencing were used to record immune signatures from a cohort of 60 patients with AIH and disease controls. Blood and liver B lineage immune metrics were not indicative of a dominant directional antigen selection apart from a slight skewing of IGHV-J genes. More importantly, we found strong AIH-specific TRBV-J skewing not attributable to the HLA-DRB1 specificities of the cohort. This TCR repertoire bias was generated as a result of peripheral T cell (de)selection and persisted in disease remission. Using a clustering algorithm according to antigenic specificity, we identified liver TCR clusters that were shared between patients with AIH but were absent or deselected in patients with other liver pathologies.CONCLUSIONS: Patients with AIH show profound and persisting T-cell architectural changes that may explain high relapse rates after tapering immunosuppression. Liver T-cell clusters shared between patients may mediate liver damage and warrant further study.

AB - BACKGROUND AND AIMS: Autoimmune hepatitis (AIH) is a chronic liver disease that regularly relapses when immunosuppression is tapered. It is thought to be driven by T-cells, whereas the etiologic impact of an apparently deregulated B lineage system, as evidenced by hypergammaglobulinemia and autoantibodies, remains elusive. We set out to investigate T and B cell repertoires supporting chronic inflammation in AIH.APPROACH AND RESULTS: T and B cell receptor (TCR/BCR) and human leukocyte antigen (HLA) next-generation immunosequencing were used to record immune signatures from a cohort of 60 patients with AIH and disease controls. Blood and liver B lineage immune metrics were not indicative of a dominant directional antigen selection apart from a slight skewing of IGHV-J genes. More importantly, we found strong AIH-specific TRBV-J skewing not attributable to the HLA-DRB1 specificities of the cohort. This TCR repertoire bias was generated as a result of peripheral T cell (de)selection and persisted in disease remission. Using a clustering algorithm according to antigenic specificity, we identified liver TCR clusters that were shared between patients with AIH but were absent or deselected in patients with other liver pathologies.CONCLUSIONS: Patients with AIH show profound and persisting T-cell architectural changes that may explain high relapse rates after tapering immunosuppression. Liver T-cell clusters shared between patients may mediate liver damage and warrant further study.

U2 - 10.1002/hep.31473

DO - 10.1002/hep.31473

M3 - SCORING: Journal article

C2 - 32692457

VL - 73

SP - 1436

EP - 1448

JO - HEPATOLOGY

JF - HEPATOLOGY

SN - 0270-9139

IS - 4

ER -